Welcome to the international HTA database

Showing [16382 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2017	National Institute for Health and Care Excellence (NICE)	Adalimumab and dexamethasone for treating non-infectious uveitis. NICE technology appraisal guidance 460
2017	HAYES, Inc.	Gore cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects
2017	National Institute for Health and Care Excellence (NICE)	Roflumilast for treating chronic obstructive pulmonary disease. NICE technology appraisal guidance 461
2017	HAYES, Inc.	Impella 2.5 System (Abiomed Inc.) for cardiac support in patients undergoing high-risk percutaneous coronary intervention
2017	National Institute for Health and Care Excellence (NICE)	Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma. NICE technology appraisal guidance 462
2017	HAYES, Inc.	Intravenous immunoglobulin for treatment of intractable epilepsy in pediatric patients
2017	National Institute for Health and Care Excellence (NICE)	Bisphosphonates for treating osteoporosis. NICE technology appraisal guidance 464
2017	HAYES, Inc.	Ketamine infusion for treatment-resistant bipolar depression
2017	National Institute for Health and Care Excellence (NICE)	Baricitinib for moderate to severe rheumatoid arthritis. NICE technology appraisal guidance 466
2017	HAYES, Inc.	Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications
2017	National Institute for Health and Care Excellence (NICE)	Holoclar for treating limbal stem cell deficiency after eye burns. NICE technology appraisal guidance 467
2017	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
2017	HAYES, Inc.	Ocrelizumab (Ocrevus; Genentech Inc.) for primary progressive and relapsing-remitting multiple sclerosis
2017	National Institute for Health and Care Excellence (NICE)	Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal). NICE technology appraisal guidance 468
2017	HAYES, Inc.	Radiofrequency nerve ablation for treatment of plantar fasciitis
2017	National Institute for Health and Care Excellence (NICE)	Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal). NICE technology appraisal guidance 469
2017	NIHR Public Health Research (PHR) programme	Evaluation of the impacts on health of the proposed UK industry levy on sugar sweetened beverages: developing a systems map and data platform, and collection of baseline and early impact data
2017	HAYES, Inc.	Raindrop near vision inlay (ReVision Optics Inc.) for presbyopia
2017	National Institute for Health and Care Excellence (NICE)	Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck. NICE technology appraisal guidance 473
2017	HAYES, Inc.	Teduglutide (Gattex; Shire-NPS Pharmaceuticals Inc.) to reduce parenteral support requirements in adults with short bowel syndrome
2017	National Institute for Health and Care Excellence (NICE)	Sorafenib for treating advanced hepatocellular carcinoma. NICE technology appraisal guidance 474
2017	HAYES, Inc.	Urolift system (NeoTract Inc.) for treatment of benign prostatic hyperplasia
2017	National Institute for Health and Care Excellence (NICE)	Dimethyl fumarate for treating moderate to severe plaque psoriasis. NICE technology appraisal guidance 475
2017	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2017	HAYES, Inc.	Afirma thyroid FNA analysis (Veracyte)
2017	National Institute for Health and Care Excellence (NICE)	Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer. NICE technology appraisal guidance 476
2017	HAYES, Inc.	AlloSure (CareDx)
2017	National Institute for Health and Care Excellence (NICE)	Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma. NICE technology appraisal guidance 478
2017	HAYES, Inc.	Cologuard (Exact Sciences Corp.)
2017	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: chemoembolization for unresectable liver metastases according to the primary origin and chemoperfusion for advanced pancreatic cancer]
2017	National Institute for Health and Care Excellence (NICE)	Reslizumab for treating severe eosinophilic asthma. NICE technology appraisal guidance 479
2017	HAYES, Inc.	GeneStrat (Biodesix Inc.)
2017	National Institute for Health and Care Excellence (NICE)	Tofacitinib for moderate to severe rheumatoid arthritis. NICE technology appraisal guidance 480
2017	HAYES, Inc.	OVA1 (ASPiRA Labs)
2017	National Institute for Health and Care Excellence (NICE)	Immunosuppressive therapy for kidney transplant in adults. NICE technology appraisal guidance 481
2017	HAYES, Inc.	ThyGenX and ThyraMIR (Interpace Diagnostics)
2017	National Institute for Health and Care Excellence (NICE)	Immunosuppressive therapy for kidney transplant in children and young people. NICE technology appraisal guidance 482
2017	HAYES, Inc.	Comparative effectiveness of bioresorbable vascular scaffold stents versus other drug-eluting stents for the treatment of coronary artery disease
2017	National Institute for Health and Care Excellence (NICE)	Sarilumab for moderate to severe rheumatoid arthritis. NICE technology appraisal guidance 485
2017	HAYES, Inc.	Comparative effectiveness of endovenous radiofrequency ablation versus conventional surgery for symptomatic varicose veins: a review of reviews
2017	National Institute for Health and Care Excellence (NICE)	Aflibercept for treating choroidal neovascularisation. NICE technology appraisal guidance 486
2017	NIHR Health Technology Assessment programme	Managing diabetes in people with dementia: a realist review
2017	HAYES, Inc.	Comparative effectiveness of skin substitutes for chronic foot ulcers in adults with diabetes mellitus: a review of reviews
2017	National Institute for Health and Care Excellence (NICE)	Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours. NICE technology appraisal guidance 488
2017	HAYES, Inc.	Comparative effectiveness of skin substitutes for chronic venous leg ulcers in adults: a review of reviews
2017	National Institute for Health and Care Excellence (NICE)	Vismodegib for treating basal cell carcinoma. NICE technology appraisal guidance 489
2017	HAYES, Inc.	Comparative effectiveness review of antimicrobial versus conventional sutures
2017	National Institute for Health and Care Excellence (NICE)	Naltrexone–bupropion for managing overweight and obesity. NICE technology appraisal guidance 494
2017	NIHR Health Technology Assessment programme	Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
2017	HAYES, Inc.	Comparative effectiveness review of endoscopic therapy for gastroesophageal reflux disease
2017	National Institute for Health and Care Excellence (NICE)	Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. NICE technology appraisal guidance 496
2017	NIHR Health Technology Assessment programme	The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations
2017	HAYES, Inc.	Comparative effectiveness review of hyaluronic acid for knee osteoarthritis: a review of reviews
2017	HAYES, Inc.	Comparative effectiveness review of minimally invasive total hip arthroplasty
2017	Norwegian Institute of Public Health (NIPH)	Assessment of conductive education for children and adolescents with brain damage: a health technology assessment
2017	HAYES, Inc.	Comparative effectiveness review of multilevel artificial disc replacement for cervical degenerative disc disease
2017	Norwegian Institute of Public Health (NIPH)	Digital Breast Tomosynthesis with Hologic 3D mammography Selenia Dimensions System for use in breast cancer screening
2017	HAYES, Inc.	Comparative effectiveness review of nonirradiated allografts for primary anterior cruciate ligament reconstruction
2017	Norwegian Institute of Public Health (NIPH)	Sutureless aortic valve replacement for treatment of severe aortic stenosis: A single technology assessment of Perceval sutureless aortic valve
2017	HAYES, Inc.	Comparative effectiveness review of platelet-rich plasma for knee osteoarthritis: a review of reviews
2017	Norwegian Institute of Public Health (NIPH)	FreeStyle Libre Flash Glucose Self-Monitoring System: A Single-Technology Assessment
2017	NIHR Health Technology Assessment programme	Researching outcomes from forensic services for people with intellectual or developmental disabilities: a systematic review, evidence synthesis and expert and patient/carer consultation
2017	HAYES, Inc.	Comparative effectiveness review of platelet-rich plasma for tendinopathies or ligament injuries of the knee
2017	Norwegian Institute of Public Health (NIPH)	Assessment of four intensive habilitation programs for children and adolescents with brain damage – a health technology assessment
2017	HAYES, Inc.	Comparative effectiveness review of platelet-rich plasma for treatment of lateral epicondylitis: a review of reviews
2017	HAYES, Inc.	Comparative effectiveness review of pyrocarbon proximal interphalangeal and metacarpophalangeal joint implants
2017	NIHR Health Technology Assessment programme	Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
2017	HAYES, Inc.	Comparative effectiveness review of total ankle replacement: a review of reviews
2017	HAYES, Inc.	Digital breast tomosynthesis for breast cancer diagnosis and screening
2017	HAYES, Inc.	Functional electrical stimulation for rehabilitation following spinal cord injury
2017	HAYES, Inc.	Hyperbaric oxygen therapy for diabetes-related foot ulcers: a review of reviews
2017	National Institute for Health and Care Excellence (NICE)	Endobronchial valve insertion to reduce lung volume in emphysema. NICE interventional procedures guidance 600
2017	NIHR Health Technology Assessment programme	A multicentre, randomised controlled trial of position during the late stages of labour in nulliparous women with an epidural: clinical effectiveness and an economic evaluation (BUMPES)
2017	NIHR Health Technology Assessment programme	A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
2017	HAYES, Inc.	Impact of preoperative supervised weight loss programs on bariatric surgery outcomes
2017	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Obstetric MRI
2017	National Institute for Health and Care Excellence (NICE)	Transcutaneous microwave ablation for severe primary axillary hyperhidrosis. NICE interventional procedures guidance 601
2017	NIHR Health Technology Assessment programme	Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation
2017	HAYES, Inc.	Ketamine as an adjunct to electroconvulsive therapy for treatment-resistant depression
2017	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration
2017	National Institute for Health and Care Excellence (NICE)	Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure. NICE interventional procedures guidance 602
2017	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Sling operation for urinary incontinence in women and men
2017	NIHR Health Technology Assessment programme	Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations
2017	HAYES, Inc.	Ketamine as primary therapy for treatment-resistant unipolar depression or posttraumatic stress disorder
2017	National Institute for Health and Care Excellence (NICE)	Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death. NICE interventional procedures guidance 603
2017	NIHR Health Technology Assessment programme	Improving risk adjustment in the PRAiS (Partial Risk Adjustment in Surgery) model for mortality after paediatric cardiac surgery and improving public understanding of its use in monitoring outcomes
2017	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Medical devices for treatment-resistant hypertension
2017	NIHR Health Technology Assessment programme	The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations
2017	HAYES, Inc.	Magnetic resonance imaging–guided in-bore biopsy for prostate cancer
2017	National Institute for Health and Care Excellence (NICE)	Transvaginal mesh repair of anterior or posterior vaginal wall prolapse. NICE interventional procedures guidance 599
2017	NIHR Health Technology Assessment programme	Multiplex tests to identify gastrointestinal bacteria, viruses and parasites in people with suspected infectious gastroenteritis: a systematic review and economic analysis
2017	HAYES, Inc.	Topical oxygen therapy for chronic wound healing
2017	National Institute for Health and Care Excellence (NICE)	Processed nerve allografts to repair peripheral nerve discontinuities. NICE interventional procedures guidance 597
2017	Belgian Health Care Knowledge Centre (KCE)	Bevacizumab in the treatment of ovarian cancer
2017	HAYES, Inc.	Transcranial direct current stimulation for depression
2017	National Institute for Health and Care Excellence (NICE)	Hypoglossal nerve stimulation for moderate to severe obstructive sleep apnoea. NICE interventional procedures guidance 598
2017	NIHR Health Technology Assessment programme	Seal or Varnish? A randomised controlled trial to determine the relative cost and effectiveness of pit and fissure sealant and fluoride varnish in preventing dental decay
2017	NIHR Health Technology Assessment programme	Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis
2017	HAYES, Inc.	Zepatier (Grazoprevir and Elbasvir) for chronic hepatitis C infection
2017	National Institute for Health and Care Excellence (NICE)	Total distal radioulnar joint replacement for symptomatic joint instability or arthritis. NICE interventional procedures guidance 595